BGMS Bio Green Med Solution Inc.

Live Feeds
Analyst Ratings
Alerts
Subscriptions
Settings
RSS Feeds

Live Feeds
Analyst Ratings
Alerts
Subscriptions
Settings
RSS Feeds

Publish Go to App

© 2025 quantisnow.com
Democratizing insights since 2022

Services

Live news feeds RSS Feeds Alerts Publish with Us

Company

About Quantisnow Plus Contact Jobs AI superconnector for talent & startupsNEW LLM Arena

Legal

Terms of use Privacy policy Cookie policy

Subscribe to $BGMS

Bio Green Med Solution Inc.

Subscribe to $BGMS

00

IPO Year:

Exchange: NASDAQ

Recent Analyst Ratings for Bio Green Med Solution Inc.

Date	Price Target	Rating	Analyst

See more ratings

Bio Green Med Solution Inc. Press Releases

Fastest customizable press release news feed in the world

Bio Green Med Solution Reports Third Quarter Financial Results and Provides Business Update

KUALA LUMPUR, Malaysia, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Bio Green Med Solution, Inc. (NASDAQ: BGMS, NASDAQ: BGMSP; "BGMS" or the "Company" (formerly Cyclacel Pharmaceuticals, Inc.)), a diversified company engaged primarily in the provision of fire safety protection and distribution activities, today announced third quarter financial results and provided a business update. Highlights of the third quarter ended September 30, 2025, or in some cases shortly thereafter, include: In July, the Company implemented a one-for-fifteen reverse stock split effective on July 7, 2025 on which day the Company's common stock began trading on a split-adjusted basis in an effort to meet the share bid

11/13/25 4:40:00 PM ET

Bio Green Med Solution Inc. SEC Filings

SEC Form S-8 filed by Bio Green Med Solution Inc.

S-8 - Bio Green Med Solution, Inc. (0001130166) (Filer)

11/28/25 4:59:50 PM ET

Amendment: SEC Form 10-K/A filed by Bio Green Med Solution Inc.

10-K/A - Bio Green Med Solution, Inc. (0001130166) (Filer)

11/26/25 5:01:16 PM ET

SEC Form 10-Q filed by Bio Green Med Solution Inc.

10-Q - Bio Green Med Solution, Inc. (0001130166) (Filer)

11/13/25 5:01:03 PM ET

Bio Green Med Solution Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

8-K - Bio Green Med Solution, Inc. (0001130166) (Filer)

11/13/25 4:50:42 PM ET

Amendment: SEC Form SCHEDULE 13G/A filed by Bio Green Med Solution Inc.

SCHEDULE 13G/A - Bio Green Med Solution, Inc. (0001130166) (Subject)

10/14/25 6:00:03 PM ET

Bio Green Med Solution Inc. filed SEC Form 8-K: Other Events

8-K - Bio Green Med Solution, Inc. (0001130166) (Filer)

10/7/25 9:01:36 AM ET

Bio Green Med Solution Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits

8-K - Bio Green Med Solution, Inc. (0001130166) (Filer)

10/7/25 9:00:34 AM ET

Bio Green Med Solution Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

8-K - Bio Green Med Solution, Inc. (0001130166) (Filer)

9/24/25 6:14:14 PM ET

Amendment: Bio Green Med Solution Inc. filed SEC Form 8-K: Other Events

8-K/A - Bio Green Med Solution, Inc. (0001130166) (Filer)

9/17/25 4:53:39 PM ET

SEC Form 424B3 filed by Bio Green Med Solution Inc.

424B3 - Bio Green Med Solution, Inc. (0001130166) (Filer)

9/17/25 4:05:17 PM ET

Bio Green Med Solution Inc. Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Chief Executive Officer Doris Wong Sing Ee was granted 300,178 shares, increasing direct ownership by 37% to 1,111,131 units (SEC Form 4)

4 - Bio Green Med Solution, Inc. (0001130166) (Issuer)

11/13/25 6:00:01 PM ET

Chief Financial Officer Kiu Cu Seng was granted 200,000 shares (SEC Form 4)

4 - Bio Green Med Solution, Inc. (0001130166) (Issuer)

11/13/25 6:00:02 PM ET

Large owner Ong Yee Lung acquired 467,535 shares (SEC Form 4)

4 - Bio Green Med Solution, Inc. (0001130166) (Issuer)

11/5/25 6:00:03 PM ET

Large owner Kua Khai Loon acquired 467,535 shares (SEC Form 4)

4 - Bio Green Med Solution, Inc. (0001130166) (Issuer)

11/5/25 6:00:03 PM ET

Large owner Yap Kim Choy sold $48,518 worth of shares (28,540 units at $1.70) and acquired 467,535 shares, increasing direct ownership by 1,538% to 467,535 units (SEC Form 4)

4 - Bio Green Med Solution, Inc. (0001130166) (Issuer)

11/5/25 6:00:05 PM ET

Large owner Yap Kim Choy sold $202,854 worth of shares (112,260 units at $1.81), decreasing direct ownership by 80% to 28,500 units (SEC Form 4)

4 - Bio Green Med Solution, Inc. (0001130166) (Issuer)

11/3/25 6:00:23 PM ET

Large owner Ong Yee Lung sold $447,865 worth of shares (248,814 units at $1.80), closing all direct ownership in the company (SEC Form 4)

4 - Bio Green Med Solution, Inc. (0001130166) (Issuer)

11/3/25 6:00:03 PM ET

Large owner Kua Khai Loon sold $436,459 worth of shares (242,477 units at $1.80), closing all direct ownership in the company (SEC Form 4)

4 - Bio Green Med Solution, Inc. (0001130166) (Issuer)

11/3/25 6:00:05 PM ET

Large owner Yap Kim Choy sold $203,114 worth of shares (110,749 units at $1.83), decreasing direct ownership by 44% to 140,760 units (SEC Form 4)

4 - Bio Green Med Solution, Inc. (0001130166) (Issuer)

10/31/25 6:00:02 PM ET

Large owner Yap Kim Choy sold $23,967 worth of shares (13,111 units at $1.83), decreasing direct ownership by 5% to 251,509 units (SEC Form 4)

4 - Bio Green Med Solution, Inc. (0001130166) (Issuer)

10/30/25 6:00:09 PM ET

Bio Green Med Solution Inc. Financials

Live finance-specific insights

Bio Green Med Solution Reports Third Quarter Financial Results and Provides Business Update

KUALA LUMPUR, Malaysia, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Bio Green Med Solution, Inc. (NASDAQ: BGMS, NASDAQ: BGMSP; "BGMS" or the "Company" (formerly Cyclacel Pharmaceuticals, Inc.)), a diversified company engaged primarily in the provision of fire safety protection and distribution activities, today announced third quarter financial results and provided a business update. Highlights of the third quarter ended September 30, 2025, or in some cases shortly thereafter, include: In July, the Company implemented a one-for-fifteen reverse stock split effective on July 7, 2025 on which day the Company's common stock began trading on a split-adjusted basis in an effort to meet the share bid

11/13/25 4:40:00 PM ET